Cohen AR - Search Results

1

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia.

Wanless IR, Sweeney G, Dhillon AP, Guido M, Piga A, Galanello R, Gamberini MR, Schwartz E, Cohen AR. Wanless IR, et al. Among authors: cohen ar. Blood. 2002 Sep 1;100(5):1566-9. doi: 10.1182/blood-2002-01-0306. Blood. 2002. PMID: 12176871 Free article. Clinical Trial.

2

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone.

Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F. Cohen AR, et al. Blood. 2003 Sep 1;102(5):1583-7. doi: 10.1182/blood-2002-10-3280. Epub 2003 May 22. Blood. 2003. PMID: 12763939 Free article. Clinical Trial.

3

A multi-center safety trial of the oral iron chelator deferiprone.

Cohen A, Galanello R, Piga A, Vullo C, Tricta F. Cohen A, et al. Ann N Y Acad Sci. 1998 Jun 30;850:223-6. doi: 10.1111/j.1749-6632.1998.tb10478.x. Ann N Y Acad Sci. 1998. PMID: 9668543 Clinical Trial.

4

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D. Cappellini MD, et al. Blood. 2006 May 1;107(9):3455-62. doi: 10.1182/blood-2005-08-3430. Epub 2005 Dec 13. Blood. 2006. PMID: 16352812 Free article. Clinical Trial.

5

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, Drelichman G, Economou M, Fattoum S, Kattamis A, Kilinc Y, Perrotta S, Piga A, Porter JB, Griffel L, Dong V, Clark J, Aydinok Y. Cappellini MD, et al. Blood. 2011 Jul 28;118(4):884-93. doi: 10.1182/blood-2010-11-316646. Epub 2011 May 31. Blood. 2011. PMID: 21628399 Free article. Clinical Trial.

6

Thalassemia.

Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Cohen AR, et al. Hematology Am Soc Hematol Educ Program. 2004:14-34. doi: 10.1182/asheducation-2004.1.14. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561674 Review.

7

Safety profile of the oral iron chelator deferiprone: a multicentre study.

Cohen AR, Galanello R, Piga A, Dipalma A, Vullo C, Tricta F. Cohen AR, et al. Br J Haematol. 2000 Feb;108(2):305-12. doi: 10.1046/j.1365-2141.2000.01866.x. Br J Haematol. 2000. PMID: 10691860 Free article.

8

Seasonal variation of pretransfusion hemoglobin levels in patients with thalassemia major.

Borgna-Pignatti C, Ventola M, Friedman D, Cohen AR, Origa R, Galanello R, Lindeman R, Francis S, Reverberi R, Volpato S. Borgna-Pignatti C, et al. Among authors: cohen ar. Blood. 2006 Jan 1;107(1):355-7. doi: 10.1182/blood-2005-03-1231. Epub 2005 Sep 22. Blood. 2006. PMID: 16179377 Free article.

9

Response to long-term deferoxamine therapy in thalassemia.

Cohen A, Martin M, Schwartz E. Cohen A, et al. J Pediatr. 1981 Nov;99(5):689-94. doi: 10.1016/s0022-3476(81)80385-x. J Pediatr. 1981. PMID: 7299539

10

Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.

Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR. Kim HC, et al. Among authors: cohen ar. Blood. 1994 Feb 15;83(4):1136-42. Blood. 1994. PMID: 8111053 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page